Michael ZürcherApr 20, 20233 min readINSIGHTSArticle 71 KVV: The case-by-case approach to reimburse pharmaceuticals – a Swiss specialty
Michael ZürcherMar 8, 20231 min readCOMPANY NEWSMeet Swizzard’s CEO Michael Zürcher at BIO-Europe Spring in Basel
Michael ZürcherFeb 15, 20233 min readINSIGHTSMarket Access in Switzerland – or how to include medical breakthroughs on the specialties list
Michael ZürcherFeb 1, 20231 min readTEAM & PARTNERSBettina Schelbert joins Swizzard as Commercial Director
Michael ZürcherDec 20, 20221 min readCOMPANY NEWSThe Swizzard Pharma AG team wishes a Merry Christmas!
Michael ZürcherDec 7, 20224 min readSWIZZARD CHAMPIONS"Enabling collaboration among member companies is the strength and success of the shqa."
Michael ZürcherNov 2, 20221 min readThree reasons why pharmaceutical companies should consider the Swiss healthcare market
Michael ZürcherOct 24, 20221 min readTEAM & PARTNERSSwizzard co-founds SMS2DACH network together with MArS (Germany) and Supersonic (Austria)
Michael ZürcherOct 19, 20224 min readSWIZZARD CHAMPIONS"Health markets are becoming the drivers of a new economic era."
